Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S O Ogren

Showing results (91-100 of 257) with videos related to

Pageof 26
Sort By:
Psychopharmacology|January 1, 1984
Role of serotonin in memory: facilitation by alaproclate and zimeldineH J Altman, D A Nordy, S O Ogren
Life Sciences. Pt. 1: Physiology and Pharmacology|November 15, 1971
A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slicesS B Ross, A L Renyi, S O Ogren
European Journal of Pharmacology|May 12, 1997
Dopamine receptor antagonists block nerve growth factor-induced hyperactivityS Kobayashi, S O Ogren, T Ebendal, et al.
Psychopharmacology Series|January 1, 1989
Animal pharmacology of raclopride, a selective dopamine D2 antagonistH Hall, S O Ogren, C Köhler, et al.
Progress in Brain Research|January 1, 1986
Functional consequences of coexistence of classical and peptide neurotransmittersT Bartfai, K Iverfeldt, E Brodin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1997
Adenosine A2A agonists: a potential new type of atypical antipsychoticR Rimondini, S Ferré, S O Ogren, et al.
Journal of Neuroendocrinology|May 12, 1998
Estrogen down-regulates mRNA encoding the exocytotic protein SNAP-25 in the rat pituitary glandG Jacobsson, H Razani, S O Ogren, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxoneA Kuzmin, J Sandin, L Terenius, et al.
Experimental Brain Research|November 5, 1997
Intraventricular injection of NGF, but not BDNF, induces rapid motor activation that is inhibited by nicotinic receptor antagonistsS Kobayashi, S O Ogren, T Ebendal, et al.
European Journal of Pharmacology|September 21, 1993
Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine releaseS O Ogren, A Pramanik, T Land, et al.
Pageof 26

Showing results (91-100 of 257) with videos related to

Sort By:
Pageof 26
Psychopharmacology|January 1, 1984
Role of serotonin in memory: facilitation by alaproclate and zimeldineH J Altman, D A Nordy, S O Ogren
Life Sciences. Pt. 1: Physiology and Pharmacology|November 15, 1971
A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slicesS B Ross, A L Renyi, S O Ogren
European Journal of Pharmacology|May 12, 1997
Dopamine receptor antagonists block nerve growth factor-induced hyperactivityS Kobayashi, S O Ogren, T Ebendal, et al.
Psychopharmacology Series|January 1, 1989
Animal pharmacology of raclopride, a selective dopamine D2 antagonistH Hall, S O Ogren, C Köhler, et al.
Progress in Brain Research|January 1, 1986
Functional consequences of coexistence of classical and peptide neurotransmittersT Bartfai, K Iverfeldt, E Brodin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1997
Adenosine A2A agonists: a potential new type of atypical antipsychoticR Rimondini, S Ferré, S O Ogren, et al.
Journal of Neuroendocrinology|May 12, 1998
Estrogen down-regulates mRNA encoding the exocytotic protein SNAP-25 in the rat pituitary glandG Jacobsson, H Razani, S O Ogren, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxoneA Kuzmin, J Sandin, L Terenius, et al.
Experimental Brain Research|November 5, 1997
Intraventricular injection of NGF, but not BDNF, induces rapid motor activation that is inhibited by nicotinic receptor antagonistsS Kobayashi, S O Ogren, T Ebendal, et al.
European Journal of Pharmacology|September 21, 1993
Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine releaseS O Ogren, A Pramanik, T Land, et al.
Pageof 26